Gadopiclenol
Specifications
933983-75-6CAS Number
2-[3,9-bis[1-carboxylato-4-(2,3-dihydroxypropylamino)-4-oxobutyl]-3,6,9,15-tetrazabicyclo[9.3.1]pentadeca-1(15),11,13-trien-6-yl]-5-(2,3-dihydroxypropylamino)-5-oxopentanoate;gadolinium(3+)IUPAC Name
C35H54GdN7O15Chemical Formula
970.1 g/molMolecular Weight
Gadopiclenol; 933983-75-6; S276568KOY; ELUCIREM; P03277; WHO 10744; P-03277; (alpha3,alpha6,alpha9-Tris(3-((2,3-dihydroxypropyl)amino)-3-oxopropyl)-3,6,9,15-tetraazabicyclo(9.3.1)pentadeca-1(15),11,13-triene-3,6,9-triacetato(3-)-kappaN3,kappaN6,kappaN9,kappaN15,kappaO3,kappaO6,kappaO9)gadolinium; gadopiclenolum; Vueway; RefChem:57320; GBCA P03277; P 03277; Gadolinium-based Magnetic Resonance Contrast Agent P03277; 3,6,9,15-Tetraazabicyclo(9.3.1)pentadeca-1(15),11,13-triene-3,6,9-triacetic acid, alpha, alpha', alpha''-tris(3-((2,3-dihydroxypropyl)amino)-3-oxopropyl)-, gadolinium salt (1:1); Gadopiclenol [USAN]; UNII-S276568KOY; Elucirem (TN); Gadopiclenol [WHO-DD]; GADOPICLENOL [INN]; Gadopiclenol (JAN/USAN/INN); SCHEMBL21682611; EX-A11498; 2-[3,9-bis[1-carboxylato-4-(2,3-dihydroxypropylamino)-4-oxobutyl]-3,6,9,15-tetrazabicyclo[9.3.1]pentadeca-1(15),11,13-trien-6-yl]-5-(2,3-dihydroxypropylamino)-5-oxopentanoate;gadolinium(3+); D12435; (.ALPHA.3,.ALPHA.6,.ALPHA.9-TRIS(3-((2,3-DIHYDROXYPROPYL)AMINO)-3-OXOPROPYL)-3,6,9,15-TETRAAZABICYCLO(9.3.1)PENTADECA-1(15),11,13-TRIENE-3,6,9-TRIACETATO(3-)-.KAPPA.N3,.KAPPA.N6,.KAPPA.N9,.KAPPA.N15,.KAPPA.O3,.KAPPA.O6,.KAPPA.O9)GADOLINIUM; GADOLINIUM, (.ALPHA.3, .ALPHA.6, .ALPHA.9-TRIS(3-((2-HYDROXY-1-(HYDROXYMETHYL)ETHYL)AMINO)-3-OXOPROPYL)-3,6,9,15-TETRAAZABICYCLO(9.3.1)PENTADECA-1(15),11,13-TRIENE-3,6,9-TRIACETATO(3-)-.KAPPA.N3, .KAPPA.N6, .KAPPA.N9, .KAPPA.N15, .KAPPA.O3, .KAPPA.O6, .KAPPA.O9)Synonyms
